Novocure Days Sales Outstanding from 2010 to 2024

NVCR Stock  USD 17.73  0.64  3.74%   
Novocure Days Sales Outstanding yearly trend continues to be relatively stable with very little volatility. Days Sales Outstanding is likely to grow to 44.14 this year. During the period from 2010 to 2024, Novocure Days Sales Outstanding destribution of quarterly values had range of 43.4808 from its regression line and mean deviation of  14.58. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
43.87197696
Current Value
44.14
Quarterly Volatility
16.56165073
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.8 M, Interest Expense of 7.7 M or Selling General Administrative of 87.6 M, as well as many indicators such as Price To Sales Ratio of 2.96, Dividend Yield of 0.0 or PTB Ratio of 4.16. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
  
Check out the analysis of Novocure Correlation against competitors.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Latest Novocure's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Novocure over the last few years. It is Novocure's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Novocure Days Sales Outstanding Regression Statistics

Arithmetic Mean43.54
Geometric Mean40.65
Coefficient Of Variation38.04
Mean Deviation14.58
Median43.87
Standard Deviation16.56
Sample Variance274.29
Range43.4808
R-Value0.70
Mean Square Error149.44
R-Squared0.49
Significance0
Slope2.60
Total Sum of Squares3,840

Novocure Days Sales Outstanding History

2024 44.14
2023 43.87
2022 58.54
2021 63.83
2020 71.39
2019 61.15
2018 53.74

About Novocure Financial Statements

Novocure shareholders use historical fundamental indicators, such as Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Days Sales Outstanding 43.87  44.14 

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.